Taylor & Francis
+5
2167-9223
8-issues-year
2.5
2167-8421
2000
4402080520500
YES
United Kingdom
English
YES
GOOGLE SCHOLAR
enquiries@taylorandfrancis.com
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is dedicated to the research of motor neuron diseases, especially ALS (Lou Gehrig’s disease) and cognitive decline associated with frontotemporal degeneration. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is the official journal of the World Federation of Neurology Research Group on Motor Neuron Diseases. It enhances awareness and disseminates information on new developments in the pathogenesis and management of ALS and FTD. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration covers the following topics related to ALS, FTD and other motor neuron diseases: Cognitive decline Basic science Genetics New treatments and clinical trials Epidemiology Clinical neurophysiology, and other clinical and scientific aspects.
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.